GI Cancer Clinical Trials
Complex gastrointestinal (GI) cancers need expert treatment. You’ll find that expertise at the University of Michigan Health Rogel Cancer Center. We provide access to the latest cancer research and the most sophisticated treatments for GI cancer.
GI Cancer Clinical Trials: Why Choose Rogel Cancer Center?
There’s no one right way to treat cancer. Our experts focus on designing personalized treatment strategies that use the newest evidence-based therapies. We offer access to cancer clinical trials for all eligible people. Program highlights include:
- Wide range of treatment trials: We lead or participate in studies of emerging treatments in different research phases. Rogel Cancer Center is one of the area’s only cancer centers offering many early-stage (phase 1) trials. Our multidisciplinary cancer care team works together to identify promising trials for eligible patients whenever possible. Meet our team.
- Proven expertise: U.S. News & World Report named Rogel Cancer Center among the best hospitals in the nation for cancer care. University of Michigan is also among the top 10 institutions globally in cancer research.
- Leading development of new therapies: Rogel Cancer Center is the lead site for a clinical trial of a new ultrasound therapy (histotripsy) for liver cancer. Our specialists are also testing new medications (systemic therapies) for GI cancers.
- Surgeries that offer hope: We’re testing new treatments using minimally invasive surgeries to remove GI cancers. Our surgical oncologists use a thin, flexible tube with a lighted camera (laparoscope) and other minimally invasive methods to reach tumors.
For help with finding clinical trials, please contact Cancer AnswerLine™ at 800-865-1125.
GI Cancer Clinical Trials at Rogel Cancer Center
We enroll eligible patients in clinical trials to test new:
GI cancer surgeries
Our experts study new ways of doing surgery that help surgeons access hard-to-reach tumors. We also study minimally invasive surgical methods that help reduce recovery time and improve health outcomes.
Radiation therapies and ablation for GI cancers
Rogel Cancer Center specialists study new methods of destroying cancer cells while preserving healthy tissue. Our experts in liver cancers lead a study of histotripsy, which uses sound waves (ultrasound) to destroy tumor cells.
Systemic therapies for GI cancers
We study new drugs to treat GI cancer more effectively and with fewer side effects, including:
- Chemotherapy: Drugs that work in your bloodstream to destroy cancer throughout the body.
- Immunotherapy: Drugs that help your immune system fight cancer cells.
- Targeted therapy: Drugs that destroy specific cancer cells while sparing healthy cells.
Find a Clinical Trial at Rogel Cancer Center
Our specialists may recommend that you enroll in a clinical trial if you are eligible to participate. We offer:
Talk to our colorectal cancers specialists to learn if a clinical trial is right for you. Our team may recommend a colorectal cancer clinical trial if you have:
- Anal cancer
- Colon cancer
- Rectal cancer
The liver cancer clinical trials at Rogel Cancer Center offer access to new therapies for people with:
- Bile duct cancer
- Gallbladder cancer
- Liver cancer
Our pancreatic cancer specialists may treat you with an emerging therapy as part of a clinical trial. Find out about our pancreatic cancer clinical trials.
Stomach (gastric) cancer clinical trials
We may recommend you for a study of a new gastric cancer treatment if you have stomach cancer. See below for a listing of our GI Clinical Trials.
GI Cancer Support Services
Rogel Cancer Center offers the support services you and your family need during treatment for GI cancer. We answer your questions and help you access information and resources. Explore our GI cancer support services.
Get help with clinical trials
Learn more about GI cancer clinical trials at Rogel Cancer Center. Call 800-865-1125.